12+ hour, 12+ min ago  (120+ words) Iryna Yaryhina, Research Engineer at Pharmaceutical company "Zdorovye, shared a post on LinkedIn: Bone is one of the most common metastatic sites in breast cancer, yet studying tumor-bone interactions remains challenging. Traditional mouse models often fail to fully recapitulate human…...

20+ hour, 23+ min ago  (159+ words) Khalid Shah, Vice Chair of Research at Brigham and Women's Hospital, Director of Center for Stem Cell and Translational Immunotherapy at Brigham and Women's Hospital, Professor at Harvard Medical School, shared a post on LinkedIn: "Excited to share our latest…...

1+ day, 20+ hour ago  (205+ words) Hung Trinh,Senior VP of Operations at Seneca Therapeutics, shared a post onLinkedIn: "Penn Medicine, University of Pennsylvania Health System and Children's Hospital of Philadelphia Philadelphia launch first CRISPR'based platform to pinpoint drivers of acute myeloid leukemia in patient cells....

5+ day, 23+ hour ago  (133+ words) Nicole Stout, Senior Director Survivorship and Wellness at American Cancer Society, shared a post by OncoDaily on LinkedIn, adding: "This is Not optional anymore. The evidence for prehab and early rehabilitation is too compelling. At some point (now?!?) we should…...

6+ day, 3+ hour ago  (99+ words) FDA Grants Full Approval of BRAFTOVI Combination Regimen in 1L Metastatic Colorectal Cancer Bishal Gyawali: ASCO Guidelines Shaped Me - Now I Help Shape What's Next Maite Bourlon: Happy to be ASCO Voice at This ASCO GU 2026 Margaret Foti: Grateful to Congress…...

6+ day, 12+ hour ago  (134+ words) Atousa Bari, Carrigent, Medical Science Liaison " Cell and Gene Therapy and Viral Vectors, shared post on LinkedIn: "Recent studies and clinical experience continue to expand the impact of CAR-T therapy. Approved CAR-T products targeting CD19 and BCMA have revolutionized treatment for…...

6+ day, 19+ hour ago  (235+ words) Patrick Soon Shiong, Chairman of Chan Soon-Shiong Family Foundation, Executive Chairman at ImmunityBio, and Executive Chairman of the Los Angeles Times, shared a post on'X: "Here is the mind map that I deconstructed for the audience at the Milken/Nixon…...

6+ day, 23+ hour ago  (228+ words) Ahmet Dirican: Gut Microbiome-Driven Modulation of the Tumor Immune Microenvironment / A. Fukuda, A. Okada, A. Yoshimura, Ahmet Dirican, cancer, ESMO, H., A. Fukuda, A. Okada, A. Yoshimura, Ahmet Dirican, cancer, ESMO, H. Kawachi, K. Takayama, M. Iwasaku, Medicana International "zmir Hospital, N. Nishioka, NSCLC, OncoDaily, Oncology, R. Inoue, R. Sawada, S. Koyama, S. Kumagai, S. Shiotsu,…...

1+ week, 3+ hour ago  (99+ words) Why Hasn't Immunotherapy Consistently Delivered in HER2+ Disease? - The Breast Friends'Oncodaily The Breast Friends Podcast shared a post on LinkedIn: "Why hasn't immunotherapy consistently delivered in HER2+ disease? Dr. Paolo Tarantino and Dr. Jason A. Mouabbi discuss a major clinical paradox: HER2 antibodies already…...

1+ week, 3+ hour ago  (409+ words) Susanna Fletcher Greer,Chief Scientific Officer of the V Foundation, shared a post onLinkedIn: "For many patients, the hardest part of cancer is when a treatment works and the disease still comes back. In aggressive lymphoma, that reality remains far…...